Department of Hematology, Clinical Immunology and Infectious Diseases
Ehime University Graduate School of Medicine
発刊済のものはabstractまたは本文にリンクしてあります。
Published papers are linked to PubMed
A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression.
Mol Ther Nucleic Acids. 2012 Dec 18;1:e63. doi: 10.1038/mtna.2012.52.
Phase I/II study of docetaxel, cisplatin and S-1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma.
Oncol Lett. 2012 Nov;4(5):898-904. Epub 2012 Aug 6.
Kanda, T., Ochi, T., Fujiwara, H., Yasukawa, M., Okamoto, S., Mineno, J., Kuzushima, K., Tsurumi, T.
HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system.
Cancer Gene Ther. 2012 Aug;19(8):566-71. doi: 10.1038/cgt.2012.34. Epub 2012 Jun 22.
Concurrent administration of rituximab and CHOP chemotherapeutic agents for outpatients with CD20-positive lymphoma.
Anticancer Agents Med Chem. 2012 Sep;12(7):829-34.
Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.
J Clin Oncol. 2012 Mar 10;30(8):837-42. doi: 10.1200/JCO.2011.37.3472. Epub 2012 Feb 6.
Role of activation-induced cytidine deaminase in the progression of follicular lymphoma.
Cancer Sci. 2012 Mar;103(3):415-21. doi: 10.1111/j.1349-7006.2011.02186.x. Epub 2012 Jan 17.
Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity.
Blood. 2012 Jan 12;119(2):368-76. doi: 10.1182/blood-2011-06-360354. Epub 2011 Oct 24.